The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Journal article published in 2019 by
Curly Morris,
Kara-Louise Royle 
,
Sheila O'Connor,
A. John Ashcroft,
Cathy D. Williams,
John A. Snowden,
Eleni Tholouli,
Christopher Parrish,
Kwee Yong,
Guy Pratt,
Treen C. M. Morris,
David Cairns,
Anna Hockaday,
Jamie D. Cavenagh,
Debo Ademokun
and other authors.
,
Sheila O'Connor,
A. John Ashcroft,
Cathy D. Williams,
John A. Snowden,
Eleni Tholouli,
Christopher Parrish,
Kwee Yong,
Guy Pratt,
Treen C. M. Morris,
David Cairns,
Anna Hockaday,
Jamie D. Cavenagh,
Debo Ademokun
and other authors.
